-+ 0.00%
-+ 0.00%
-+ 0.00%

Marker Therapeutics FY 2025 net loss widens 13% to USD 12.16 million as grant income falls 46% to USD 3.55 million

Reuters·03/18/2026 21:28:40

Please log in to view news